![[Yakup] C&R Research, Trial Informatics, And Microsoft Korea Signed An MOU To ‘Develop IT Solution For Clinical Trials Using Microsoft Azure AI’](https://www.cnrres.com/wp-content/uploads/2021/04/CR-CI_홈페이지-기사-업로드용.png)
C&R Research, Trial Informatics, and Microsoft Korea signed an MOU to 'Develop IT solution for Clinical Trials using Microsoft Azure…
C&R Research (CEO Moon-Tae Yoon) announced the commencement of pre-registration for a free clinical trial symposium for pharmaceutical industry professionals,…
C&R Research and 'EYEBIOKOREA' signed an MOU to 'Efficiently manage clinical trials for ophthalmic diseases and enhance global clinical competitiveness'.…
'New things, always by us!' made C&R Research No.1 CRO in South Korea. Byungjin Ahn, President of C&R Research,…
C&R Research and 'Chonnam National University Hwasun Hospital' signed an MOU to 'Strengthen Data Utilization in Clinical Research'. Through…
C&R Research successfully carried out EMA approval for the Phase 3 IND clinical trial of ‘EYELEA’ Biosimilar with Rophibio, Inc.…
C&R Research and GC Cell signed an MOU to strengthen global clinical competitiveness and sales power. Through this business…
C&R Research (CEO Moon-Tae Yoon) announced about conducting a Phase 1 clinical trial for 'Non-Small Cell Lung Cancer' of ONCOBIX…
C&R Research successfully carried out US FDA approval for the Phase 3 IND clinical trial of 'EYELEA' Biosimilar with Rophibio,…
C&R Research (CEO Moon-Tae Yoon) successfully carried out the US FDA medical device 510(k) approval work, expanding business scope to…